ANTXR2

From WikiProjectMed
Jump to navigation Jump to search
ANTXR2
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesANTXR2, CMG-2, CMG2, HFS, ISH, JHF, anthrax toxin receptor 2, ANTXR cell adhesion molecule 2
External IDsOMIM: 608041 MGI: 1919164 HomoloGene: 43236 GeneCards: ANTXR2
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001145794
NM_001286780
NM_001286781
NM_058172

NM_133738

RefSeq (protein)

NP_001139266
NP_001273709
NP_001273710
NP_477520
NP_001273710.1

NP_598499

Location (UCSC)Chr 4: 79.9 – 80.13 MbChr 5: 98.03 – 98.18 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Anthrax toxin receptor 2 (also known as capillary morphogenesis gene 2 or CMG2) is a protein that in humans is encoded by the ANTXR2 gene.[5][6][7]

Mutations in ANTXR2 are associated with infantile systemic hyalinosis[8][9] and juvenile systemic hyalinosis, both autosomal recessive disorders.[10][11] Biallelic missense mutations of ANTXR2 have been described in a case report of atypical infantile systemic hyalinosis with intestinal lymphangiectasia causing protein-losing enteropathy.[12][13] Deuquet et al. (2009) found that three out of four missense mutations in the von Willebrand domain of ANTXR2 identified from cases of infantile systemic hyalinosis resulted in partial or complete retention of the protein in the endoplasmic reticulum (ER) of transfected HeLa cells and anthrax toxin receptor–deficient Chinese hamster ovary cells, as did a mutation in the transmembrane domain. They speculate that, for certain mutations, assisting the proper folding and surface expression of ANTXR2 by chemical chaperones may allow for rescue of phenotype, as these proteins appeared to be relatively stable in the ER without rapid degradation by endoplasmic-reticulum-associated protein degradation.[8]

See also

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000163297Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000029338Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Bell SE, Mavila A, Salazar R, Bayless KJ, Kanagala S, Maxwell SA, et al. (Oct 2001). "Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling". J Cell Sci. 114 (Pt 15): 2755–73. doi:10.1242/jcs.114.15.2755. PMID 11683410.
  6. ^ Scobie HM, Rainey GJ, Bradley KA, Young JA (Apr 2003). "Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor". Proc Natl Acad Sci U S A. 100 (9): 5170–4. Bibcode:2003PNAS..100.5170S. doi:10.1073/pnas.0431098100. PMC 154317. PMID 12700348.
  7. ^ "Entrez Gene: ANTXR2 anthrax toxin receptor 2".
  8. ^ a b Deuquet J, Abrami L, Difeo A, Ramirez MC, Martignetti JA, Gisou van der Goot F (2009). "Systemic Hyalinosis Mutations in the CMG2 Ectodomain Leading to Loss of Function Through Retention in the Endoplasmic Reticulum". Human Mutation. 30 (4): 583–589. doi:10.1002/humu.20872. PMID 19191226.
  9. ^ Kniffin CL, McKusick VA (14 January 2013) [Originally published 3 June 1986]. "HYALINE FIBROMATOSIS SYNDROME; HFS". Online Mendelian Inheritance in Man. #228600. Retrieved 30 January 2024.
  10. ^ Dowling O, Difeo A, Ramirez MC, Tukel T, Narla G, Bonafe L, et al. (2003). "Mutations in Capillary Morphogenesis Gene-2 Result in the Allelic Disorders Juvenile Hyaline Fibromatosis and Infantile Systemic Hyalinosis". The American Journal of Human Genetics. 73 (4): 957–966. doi:10.1086/378781. PMC 1180616. PMID 12973667.
  11. ^ El-Kamah GY, Fong K, El-Ruby M, Afifi HH, Clements SE, Lai-Cheong JE, et al. (2010). "Spectrum of mutations in the ANTXR2 (CMG2) gene in infantile systemic hyalinosis and juvenile hyaline fibromatosis". British Journal of Dermatology. 163 (1): 213–215. doi:10.1111/j.1365-2133.2010.09769.x. PMID 20331448. S2CID 232096.
  12. ^ Alreheili K, AlMehaidib A, Alsaleem K, Banemi M, Aldekhail W, Al-Mayouf SM (2012). "Intestinal lymphangiectasia in a patient with infantile systemic hyalinosis syndrome: a rare cause of protein-losing enteropathy". Annals of Saudi Medicine. 32 (2): 206–208. doi:10.5144/0256-4947.2012.206. PMC 6086646. PMID 22366835.
  13. ^ Ozen A, Lenardo MJ (2023). "Protein-Losing Enteropathy". The New England Journal of Medicine. 389 (8): 733–748. doi:10.1056/NEJMra2301594. PMID 37611123. S2CID 261099908.

External links

Further reading